# Autologous Mesenchymal Stem Cell Transplantation in Cirrhosis Patients With Refractory Ascites

> **NCT01854125** · PHASE3 · UNKNOWN · sponsor: **Nanjing PLA General Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Immune Function in Blood
- Liver Function in Blood
- Variation of Ascites
- Characters of Quality of Life
- Child-Pugh Score

## Interventions

- **BIOLOGICAL:** autologous bone marrow mesenchymal stem cells transplantation
- **BIOLOGICAL:** autologous bone marrow msenchymal stem cells transplantation

## Key facts

- **NCT ID:** NCT01854125
- **Lead sponsor:** Nanjing PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2014-01
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854125, "Autologous Mesenchymal Stem Cell Transplantation in Cirrhosis Patients With Refractory Ascites". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01854125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*